18.7.2016 EN Official Journal of the European Union C 260/39 Order of the General Court of 25 May 2016 — Stagecoach Group v EUIPO (MEGABUS.COM) (Case T-805/14) (1) (European Union trade mark — Application for a European Union word mark MEGABUS.COM — Absolute grounds for refusal — Lack of distinctive character — Article 7(1)(b) of Regulation (EC) No 207/2009 — Descriptive character — Article 7(1)(c) of Regulation No 207/2009 — Article 7(3) of Regulation No 207/2009 — Article 75 of Regulation No 207/2009 — Action manifestly inadmissible and manifestly lacking any foundation in law) (2016/C 260/48) Language of the case: English Parties Applicant: Stagecoach Group plc (Perth, United Kingdom) (represented by: G. Jacobs, lawyer) Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent) Re: Action brought against the decision of the Fourth Board of Appeal of EUIPO of 7 October 2014 (Case R 1894/2013-4) concerning an application for registration of the word sign MEGABUS.COM as a European Union trade mark. Operative part of the order 1. The action is dismissed as being in part manifestly inadmissible and in part manifestly lacking any foundation in law. 2. Stagecoach Group plc shall pay the costs. (1) OJ C 34, 2.2.2015. Order of the President of the General Court of 23 May 2016 — Pari Pharma v EMA (Case T-235/15 R) (Application for interim measures — Access to documents — Regulation (EC) No 1049/2001 — Documents held by the EMA concerning information submitted by an undertaking as part of its application for authorisation to place a medicinal product on the market — Order granting suspension of operation of the decision to grant a third party access to the documents — Application for cancellation — No change in circumstances — Article 159 of the Rules of Procedure of the General Court) (2016/C 260/49) Language of the case: English Parties Applicant: Pari Pharma GmbH (Starnberg, Germany) (represented by: M. Epping and W. Rehmann, lawyers) Defendant: European Medicines Agency (represented by: T. Jabłoński, N. Rampal Olmedo, A. Spina, A. Rusanov and S. Marino, acting as Agents) Intervener in support of the defendant: Novartis Europharm Ltd (Camberley, United Kingdom) (represented by: C. Schoonderbeek, lawyer).